您的位置: 首页 > 农业专利 > 详情页

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
专利权人:
Phoenix Biotechnology Inc.
发明人:
Yang, Peiying,Newman, Robert A.,Addington, Crandell O.
申请号:
AU2008321225
公开号:
AU2008321225B2
申请日:
2008.11.06
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
A prognostic assay and kit and method of use thereof are provided. The kit and assay are used to determine the likelihood of a diseased cell or tissue having a therapeutic response to treatment with a cardiac glycoside in a disease having an etiology associated with excessive cell proliferation. The kit and assay are used to determine the ratio of isoforms of the α subunit of Na, K-ATPase obtained from the diseased cell or tissue. The kit can be used to predict the therapeutic responsiveness of cancer or tumor in a subject to treatment with a cardiac glycoside. The kit and assay can be incorporated in a method of treating a disease or disorder having an etiology associated with excessive cell proliferation with a composition comprising a cardiac glycoside.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充